The treatment of patients with low tumour burden and/or slow growing disease.
In the evaluation of the wide range of novel therapeutics which have been developed, investigators do not have to be tied to the current paradigm of demonstrating additive efficacy to first line combination therapy. The addition of new agents to FOLFOX regimens has proved a high hurdle at which many...
Yazar: | Maughan, T |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2011
|
Benzer Materyaller
-
The response of fast-, medium- and slow-growing chickens to a low protein diet
Yazar:: Darina Chodová, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01) -
Is visual radiological evaluation of liver tumour burden in patients with neuroendocrine tumours reproducible?
Yazar:: Magaly Zappa, ve diğerleri
Baskı/Yayın Bilgisi: (2017-02-01) -
STING signalling compensates for low tumour mutation burden to drive anti-tumour immunityResearch in context
Yazar:: Jiayi Tan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-03-01) -
Slow growing of Stieltjes integrals of monotone functions
Yazar:: M. V. Zabolotskyj, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01) -
Cassava residues in the diet of slow-growing broilers
Yazar:: Silvia Silva VIEIRA, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)